易损与稳定颈动脉粥样硬化斑块中的病毒病原体及炎症细胞因子全身水平
前瞻性收集2019年7月至12月因显著狭窄行颈动脉内膜切除术的连续患者资料,检测斑块内EBV、CMV、HSV、VZV及流感病毒基因组并测定血清TNF-α、IL-1β、IL-6、IL-10和CCL5水平,与斑块组织学易损性相关分析。共分析50例患者,31例(62%)为易损斑块;未接种流感疫苗者易损斑块比例高于接种者(82% vs 36%,P=0.001),易损斑块患者血清TNF-α和IL-6水平高于稳定斑块患者。
要点
- 50例颈动脉内膜切除术患者中31例(62%)为易损斑块,仅2例易损斑块中部检出EBV基因组。
- 未接种流感疫苗者易损斑块比例82%(23/28),高于接种者的36%(8/22),P=0.001。
- 易损斑块患者血清TNF-α和IL-6水平高于稳定斑块患者,且独立于合并症、病毒暴露或流感疫苗接种。
核心结论
- EBV基因组见于2例易损颈动脉斑块的中部,其相邻对照区未检出。
- 流感疫苗接种与较低的颈动脉斑块易损性发生率相关。
- 易损斑块患者血清TNF-α和IL-6水平高于稳定斑块患者。
研究设计与样本
- 前瞻性收集2019年7月至12月因显著狭窄连续接受颈动脉内膜切除术患者的资料,共分析50例患者的数据。
- 在斑块中部及相邻无斑块侧部检测EBV、CMV、HSV、VZV和流感病毒基因组,并测定血清TNF-α、IL-1β、IL-6、IL-10和CCL5水平,结果与切除斑块的组织学易损性相关分析。
- P值<0.05视为有统计学意义。
主要发现
- 31例(62%)检出易损斑块;所有血管样本均未检出CMV、HSV、VZV和流感病毒基因组。
- EBV基因组见于2例易损斑块的中部,其各自对照区未检出。
- 未接种流感疫苗者中82%(23/28)为易损颈动脉斑块,接种者中为36%(8/22),P=0.001。
- 易损斑块患者血清TNF-α为73.6±238.2 pg/ml,稳定斑块患者为3.9±13.1 pg/ml,P=0.01。
- 易损斑块患者血清IL-6为45.9±103.6 pg/ml,稳定斑块患者为10.1±25.3 pg/ml,P=0.01;上述差异独立于合并症、病毒暴露或流感疫苗接种。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the presence of genetic material of viral agents and the serum level of inflammatory cytokines in patients submitted to carotid endarterectomy having vulnerable versus stable atherosclerotic plaques. METHODS: Data of patients consecutively submitted to carotid endarterectomy for a significant stenosis from July 2019 to December 2019 were prospectively collected. The genetic material of Epstein-Barr (EBV), CitoMegalo (CMV), Herpes Simplex (HSV), Varicella-Zoster (VZV) and Influenza (IV) Viruses was searched in the patient's plaques, both in the "mid" of the plaque and in an adjacent lateral portion of no-plaque area. The serum levels of TNF-α, IL-1β, IL-6, IL10 and CCL5 were determined. The obtained results were then correlated to the histologic vulnerability of the removed carotid plaque. P values < 0.05 were considered statistically significant. RESULTS: Data of 50 patients were analyzed. A vulnerable plaque was found in 31 patients (62%). The genome of CMV, HSV, VZV and IV was not found in any of the vascular samples, while the EBV genome was found in the "mid" of 2 vulnerable plaques, but not in their respective control area. Eighty-two percent of patients who did not receive anti-IV vaccination (23/28) had vulnerable carotid plaque, compared with 36% of vaccinated patients (8/22, P = 0.001). Serum levels of TNF-α and IL-6 were higher in patients with a vulnerable plaque compared to patients with a stable plaque (73.6 ± 238.2 vs. 3.9 ± 13.1 pg/ml, P= 0.01, and 45.9 ± 103.6 vs. 10.1 ± 25.3 pg/ml, P= 0.01, respectively), independent of comorbidities, viral exposure or flu vaccination. CONCLUSIONS: The EBV genome was found in the "core" of 2 vulnerable carotid plaques, but not in their respective adjacent control. Influenza vaccination was associated with a lower incidence of carotid plaque vulnerability. Serum levels of TNF-α and IL-6 were higher in patients with a vulnerable plaque compared to patients with a stable plaque.
引用
- Mazzaccaro D, Dolci M, Perego F, et al. Viral Agents and Systemic Levels of Inflammatory Cytokines in Vulnerable and Stable Atherosclerotic Carotid Plaques. Ann Vasc Surg. 2021. PMID: 34902464. doi:10.1016/j.avsg.2021.10.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。